136 related articles for article (PubMed ID: 11371659)
1. Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?
Schmaldienst S; Müllner M; Goldammer A; Spitzauer S; Banyai S; Hörl WH; Derfler K
Rheumatology (Oxford); 2001 May; 40(5):513-21. PubMed ID: 11371659
[TBL] [Abstract][Full Text] [Related]
2. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
3. New trends in specific immunoadsorption.
Ullrich H; Kuehnl P
Transfus Apher Sci; 2004 Jun; 30(3):223-31. PubMed ID: 15172628
[TBL] [Abstract][Full Text] [Related]
4. Low rate of infectious complications following immunoadsorption therapy without regular substitution of intravenous immunoglobulins.
Tselmin S; Julius U; Bornstein SR; Hohenstein B
Atheroscler Suppl; 2017 Nov; 30():278-282. PubMed ID: 29096850
[TBL] [Abstract][Full Text] [Related]
5. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
Koll RA
Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
[TBL] [Abstract][Full Text] [Related]
6. Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis.
Lazaridis K; Dalianoudis I; Baltatzidi V; Tzartos SJ
J Neuroimmunol; 2017 Nov; 312():24-30. PubMed ID: 28912035
[TBL] [Abstract][Full Text] [Related]
7. Peptide based adsorbers for therapeutic immunoadsorption.
Rönspeck W; Brinckmann R; Egner R; Gebauer F; Winkler D; Jekow P; Wallukat G; Müller J; Kunze R
Ther Apher Dial; 2003 Feb; 7(1):91-7. PubMed ID: 12921122
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption with regenerating systems in neurological disorders --A single center experience.
Hohenstein B; Passauer J; Ziemssen T; Julius U
Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315
[TBL] [Abstract][Full Text] [Related]
9. ABO-incompatible kidney transplantation using regenerative selective immunoglobulin adsorption.
Teschner S; Stippel D; Grunenberg R; Beck B; Wahba R; Gathof B; Benzing T; Burst V
J Clin Apher; 2012; 27(2):51-60. PubMed ID: 22271603
[TBL] [Abstract][Full Text] [Related]
10. Safety Aspects of Immunoadsorption in IgG Removal Using a Single-Use, Multiple-pass Protein A Immunoadsorber (LIGASORB): Clinical Investigation in Healthy Volunteers.
Süfke S; Lehnert H; Uhlenbusch-Körwer I; Gebauer F
Ther Apher Dial; 2017 Aug; 21(4):405-413. PubMed ID: 28508563
[TBL] [Abstract][Full Text] [Related]
11. Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications.
Fuchs K; Rummler S; Ries W; Helmschrott M; Selbach J; Ernst F; Morath C; Gauly A; Atiye S; Stauss-Grabo M; Giefer M
Ther Apher Dial; 2022 Feb; 26(1):229-241. PubMed ID: 33914397
[TBL] [Abstract][Full Text] [Related]
12. Immunoadsorption in the treatment of pemphigus.
Mlynek A; Meurer M
Atheroscler Suppl; 2009 Dec; 10(5):107-9. PubMed ID: 20129386
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous immunoglobulins. General features and the main clinical applications].
Agostini G; Antonelli A
Clin Ter; 1992 Sep; 141(9 Pt 2):17-32. PubMed ID: 1468194
[TBL] [Abstract][Full Text] [Related]
14. Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgaris.
Dietze J; Hohenstein B; Tselmin S; Julius U; Bornstein SR; Beissert S; Günther C
Atheroscler Suppl; 2017 Nov; 30():271-277. PubMed ID: 29096849
[TBL] [Abstract][Full Text] [Related]
15. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
Hurez V; Kaveri SV; Kazatchkine MD
J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
[TBL] [Abstract][Full Text] [Related]
16. Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells.
Opgenoorth M; Wagner A; Passauer J; Hohenstein B; Hugo C
Atheroscler Suppl; 2015 May; 18():67-73. PubMed ID: 25936307
[TBL] [Abstract][Full Text] [Related]
17. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
Shimanovich I; Nitschke M; Rose C; Grabbe J; Zillikens D
Br J Dermatol; 2008 Feb; 158(2):382-8. PubMed ID: 18070210
[TBL] [Abstract][Full Text] [Related]
19. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.
Greinacher A; Friesecke S; Abel P; Dressel A; Stracke S; Fiene M; Ernst F; Selleng K; Weissenborn K; Schmidt BM; Schiffer M; Felix SB; Lerch MM; Kielstein JT; Mayerle J
Lancet; 2011 Sep; 378(9797):1166-73. PubMed ID: 21890192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
